Drugs / ASP7657
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02108548 | Apr 2014 → Mar 2015 | — | Astellas Pharma Europe B.V. | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASP7657 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02108548 ↗ |
| Modality | Small molecule | — CHEMBL6068537 ↗ |
| Route | Oral | “oral” NCT02108548 ↗ |